These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8816926)

  • 1. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
    Periyasamy S; Sun L; Gentry LE; Brattain MG
    J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.
    Boumediene K; Félisaz N; Pujol JP
    Exp Cell Res; 1998 Aug; 243(1):173-84. PubMed ID: 9716461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
    Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
    Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
    Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
    Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
    Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
    Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J; Buick RN
    Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.